GMO Strategic Opportunities Allocation Fund;III
$20.27+$0.04 (+0.2%)
GMO Strategic Opportunities Allocation Fund;III’s quoted price sits in the upper half of its reported 52-week range, 0.88% below the high.
NASDAQ · GGSOX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 12:06 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Grandeur Peak Global Stalwarts Fund Investor Class’s quoted price sits in the upper half of its reported 52-week range, 6.98% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Grandeur Peak Global Stalwarts Fund Investor Class’s forward annual dividend is $2.48 per share, paid annual. The forward yield is 14.11% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
This fund aims to achieve sustained capital appreciation over the long term. Under typical market conditions, the advisor predominantly invests in equity securities of companies, both international and U.S.-based, that possess a market capitalization exceeding $1.5 billion when initially acquired. A substantial portion of the fund's total holdings will be dedicated to securities from companies headquartered outside the United States. Furthermore, it has the discretion to allocate a considerable share of its assets to securities issued by entities based in emerging and frontier economies.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:24 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$20.27+$0.04 (+0.2%)
GMO Strategic Opportunities Allocation Fund;III’s quoted price sits in the upper half of its reported 52-week range, 0.88% below the high.
$21.19-$0.16 (-0.75%)
F/m Investments Large Cap Focused Inv’s quoted price sits in the upper half of its reported 52-week range, 7.95% below the high.
$21.82-$0.17 (-0.77%)
F/m Investments Large Cap Focused Fund;Inst’s quoted price sits in the upper half of its reported 52-week range, 7.93% below the high.
$14.62+$0.02 (+0.1%)
Royce Global Trust, Inc.’s quoted price sits in the upper half of its reported 52-week range, 7.41% below the high.
$333.24-$7.08 (-2.08%)
Rydex Technology Inv’s quoted price sits in the upper half of its reported 52-week range, 8.72% below the high.
$68.44-$0.71 (-1.03%)
Saturna Growth Fund - Investor Shares’s quoted price sits in the upper half of its reported 52-week range, 4.08% below the high.
$19.17-$0.03 (-0.14%)
The Lazard Funds, Inc. - Lazard Global Equity Select Portfolio’s quoted price sits in the upper half of its reported 52-week range, 2.87% below the high.
$17.93+$0.24 (+1.36%)
Grandeur Peak Global Stalwarts Fund Institutional Class’s quoted price sits in the upper half of its reported 52-week range, 6.91% below the high.